Bernhard E. Spiess - Chief Business Officer at Castle Biosciences Inc

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	14.7K	$299K	$20.36	Dec 10, 2021	Direct
Restricted Stock Units	4.5K	$90.8K	$20.17	Dec 10, 2021	Direct	Common Stock

Showing 1 to 2 of 2 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.